HopeStage
Back to all studies
CompletedNCT01887990

Intravenous Ketamine for Depression and Suicidal Thoughts

About this titleRead the official source — NCT01887990
Medication studyAges 19+United StatesSuicide prevention
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 19 years.

Listed locations
BirminghamSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 2012
Recruitment status
Completed
Enrollment listed in the registry
18
Sponsor
University of Alabama at Birmingham
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
Over 19 Years
Official registry ID
NCT01887990
Official title
Show the full official title

Treatment of Suicidal Ideation With Intravenous Ketamine Infusion

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Alabama at Birmingham, a university.

Did this study involve medication?

Yes. The study involved medication, including ketamine and placebo.

Who was this study for?

Listed age limits: from 19 years.

Want to explore more studies?

Explore studies